Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Francisco Alves; Inês F Antunes; Emiliano Cazzola; Frederik Cleeren; Bart Cornelissen; Antonia Denkova; Jonathan Engle; Alain Faivre-Chauvet; Nic Gillings; Jeroen J M A Hendrikx; Amir R Jalilian; Nicholas P van der Meulen; Renata Mikolajczak; Oliver C Neels; Maroor R A Pillai; Raymond Reilly; Sietske Rubow; Yann Seimbille; Sarah Spreckelmeyer; Wiktor Szymanski; Carlotta Taddei

doi:10.1186/s41181-021-00146-9

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Francisco Alves, Inês F Antunes, Emiliano Cazzola, Frederik Cleeren, Bart Cornelissen, Antonia Denkova, Jonathan Engle, Alain Faivre-Chauvet, Nic Gillings, Jeroen J M A Hendrikx, Amir R Jalilian, Nicholas P van der Meulen, Renata Mikolajczak, Oliver C Neels, Maroor R A Pillai, Raymond Reilly, Sietske Rubow, Yann Seimbille, Sarah Spreckelmeyer, Wiktor SzymanskiCarlotta Taddei

Department of Clinical Physiology, Nuclear Medicine & PET

Abstract

BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development.

RESULTS: This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included.

CONCLUSIONS: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

Original language	English
Article number	31
Journal	EJNMMI radiopharmacy and chemistry
Volume	6
Issue number	1
Pages (from-to)	31
ISSN	2365-421X
DOIs	https://doi.org/10.1186/s41181-021-00146-9
Publication status	Published - 8 Sept 2021

Access to Document

10.1186/s41181-021-00146-9

Cite this

Alves, F., Antunes, I. F., Cazzola, E., Cleeren, F., Cornelissen, B., Denkova, A., Engle, J., Faivre-Chauvet, A., Gillings, N., Hendrikx, J. J. M. A., Jalilian, A. R., van der Meulen, N. P., Mikolajczak, R., Neels, O. C., Pillai, M. R. A., Reilly, R., Rubow, S., Seimbille, Y., Spreckelmeyer, S., ... Taddei, C. (2021). Highlight selection of radiochemistry and radiopharmacy developments by editorial board. EJNMMI radiopharmacy and chemistry, 6(1), 31. Article 31. https://doi.org/10.1186/s41181-021-00146-9

Alves, F, Antunes, IF, Cazzola, E, Cleeren, F, Cornelissen, B, Denkova, A, Engle, J, Faivre-Chauvet, A, Gillings, N, Hendrikx, JJMA, Jalilian, AR, van der Meulen, NP, Mikolajczak, R, Neels, OC, Pillai, MRA, Reilly, R, Rubow, S, Seimbille, Y, Spreckelmeyer, S, Szymanski, W & Taddei, C 2021, 'Highlight selection of radiochemistry and radiopharmacy developments by editorial board', EJNMMI radiopharmacy and chemistry, vol. 6, no. 1, 31, pp. 31. https://doi.org/10.1186/s41181-021-00146-9

@article{72aca47a4d4d492a87cb60ea65769cca,

title = "Highlight selection of radiochemistry and radiopharmacy developments by editorial board",

abstract = "BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development.RESULTS: This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included.CONCLUSIONS: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.",

author = "Francisco Alves and Antunes, {In{\^e}s F} and Emiliano Cazzola and Frederik Cleeren and Bart Cornelissen and Antonia Denkova and Jonathan Engle and Alain Faivre-Chauvet and Nic Gillings and Hendrikx, {Jeroen J M A} and Jalilian, {Amir R} and {van der Meulen}, {Nicholas P} and Renata Mikolajczak and Neels, {Oliver C} and Pillai, {Maroor R A} and Raymond Reilly and Sietske Rubow and Yann Seimbille and Sarah Spreckelmeyer and Wiktor Szymanski and Carlotta Taddei",

note = "{\textcopyright} 2021. The Author(s).",

year = "2021",

month = sep,

day = "8",

doi = "10.1186/s41181-021-00146-9",

language = "English",

volume = "6",

pages = "31",

journal = "EJNMMI radiopharmacy and chemistry",

issn = "2365-421X",

publisher = "SpringerOpen",

number = "1",

}

TY - JOUR

T1 - Highlight selection of radiochemistry and radiopharmacy developments by editorial board

AU - Alves, Francisco

AU - Antunes, Inês F

AU - Cazzola, Emiliano

AU - Cleeren, Frederik

AU - Cornelissen, Bart

AU - Denkova, Antonia

AU - Engle, Jonathan

AU - Faivre-Chauvet, Alain

AU - Gillings, Nic

AU - Hendrikx, Jeroen J M A

AU - Jalilian, Amir R

AU - van der Meulen, Nicholas P

AU - Mikolajczak, Renata

AU - Neels, Oliver C

AU - Pillai, Maroor R A

AU - Reilly, Raymond

AU - Rubow, Sietske

AU - Seimbille, Yann

AU - Spreckelmeyer, Sarah

AU - Szymanski, Wiktor

AU - Taddei, Carlotta

PY - 2021/9/8

Y1 - 2021/9/8

N2 - BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development.RESULTS: This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included.CONCLUSIONS: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

AB - BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development.RESULTS: This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included.CONCLUSIONS: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

UR - http://www.scopus.com/inward/record.url?scp=85114456758&partnerID=8YFLogxK

U2 - 10.1186/s41181-021-00146-9

DO - 10.1186/s41181-021-00146-9

M3 - Review

C2 - 34495412

SN - 2365-421X

VL - 6

SP - 31

JO - EJNMMI radiopharmacy and chemistry

JF - EJNMMI radiopharmacy and chemistry

IS - 1

M1 - 31

ER -

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Abstract

Access to Document

Other files and links

Fingerprint

Cite this